0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nicotinamide Phosphoribosyltransferase Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-18R9482
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Nicotinamide Phosphoribosyltransferase Market Insights and Forecast to 2028
BUY CHAPTERS

Global Nicotinamide Phosphoribosyltransferase Market Research Report 2023

Code: QYRE-Auto-18R9482
Report
March 2023
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Nicotinamide Phosphoribosyltransferase Market

The global Nicotinamide Phosphoribosyltransferase market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Nicotinamide Phosphoribosyltransferase include Genentech, Inc., Angelini Group, Calico LLC, FORMA Therapeutics, Inc., OncoTartis, Inc., Karyopharm Therapeutics, Inc. and Aurigene Discovery Technologies Limited, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Phosphoribosyltransferase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Phosphoribosyltransferase.
The Nicotinamide Phosphoribosyltransferase market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nicotinamide Phosphoribosyltransferase market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicotinamide Phosphoribosyltransferase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Genentech, Inc.
  • Angelini Group
  • Calico LLC
  • FORMA Therapeutics, Inc.
  • OncoTartis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Aurigene Discovery Technologies Limited

Segment by Type

  • Hormone
  • Lipids
  • Small Molecule Compounds
  • Others

Segment by Application

  • Parkinson's Disease
  • Acute Lung Injury
  • Breast Cancer
  • Others

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nicotinamide Phosphoribosyltransferase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nicotinamide Phosphoribosyltransferase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Nicotinamide Phosphoribosyltransferase Market Report

Report MetricDetails
Report NameGlobal Nicotinamide Phosphoribosyltransferase Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Nicotinamide Phosphoribosyltransferase Market Overview
1.1 Product Overview and Scope of Nicotinamide Phosphoribosyltransferase
1.2 Nicotinamide Phosphoribosyltransferase Segment by Type
1.2.1 Global Nicotinamide Phosphoribosyltransferase Market Value Comparison by Type (2023-2029)
1.2.2 Hormone
1.2.3 Lipids
1.2.4 Small Molecule Compounds
1.2.5 Others
1.3 Nicotinamide Phosphoribosyltransferase Segment by Application
1.3.1 Global Nicotinamide Phosphoribosyltransferase Market Value by Application: (2023-2029)
1.3.2 Parkinson's Disease
1.3.3 Acute Lung Injury
1.3.4 Breast Cancer
1.3.5 Others
1.4 Global Nicotinamide Phosphoribosyltransferase Market Size Estimates and Forecasts
1.4.1 Global Nicotinamide Phosphoribosyltransferase Revenue 2018-2029
1.4.2 Global Nicotinamide Phosphoribosyltransferase Sales 2018-2029
1.4.3 Global Nicotinamide Phosphoribosyltransferase Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nicotinamide Phosphoribosyltransferase Market Competition by Manufacturers
2.1 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nicotinamide Phosphoribosyltransferase Average Price by Manufacturers (2018-2023)
2.4 Global Nicotinamide Phosphoribosyltransferase Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Product Type & Application
2.7 Nicotinamide Phosphoribosyltransferase Market Competitive Situation and Trends
2.7.1 Nicotinamide Phosphoribosyltransferase Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nicotinamide Phosphoribosyltransferase Players Market Share by Revenue
2.7.3 Global Nicotinamide Phosphoribosyltransferase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nicotinamide Phosphoribosyltransferase Retrospective Market Scenario by Region
3.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nicotinamide Phosphoribosyltransferase Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2018-2029
3.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2018-2023
3.2.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2024-2029
3.3 Global Nicotinamide Phosphoribosyltransferase Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2018-2029
3.3.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2018-2023
3.3.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2024-2029
3.4 North America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
3.4.1 North America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nicotinamide Phosphoribosyltransferase Sales by Country (2018-2029)
3.4.3 North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
3.5.1 Europe Nicotinamide Phosphoribosyltransferase Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2018-2029)
3.5.3 Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
3.6.1 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Country (2018-2029)
3.6.3 Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
3.7.1 Latin America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nicotinamide Phosphoribosyltransferase Sales by Country (2018-2029)
3.7.3 Latin America Nicotinamide Phosphoribosyltransferase Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2018-2029)
4.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2018-2023)
4.1.2 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2024-2029)
4.1.3 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2018-2029)
4.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2018-2029)
4.2.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2018-2023)
4.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2024-2029)
4.2.3 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2018-2029)
4.3 Global Nicotinamide Phosphoribosyltransferase Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2018-2029)
5.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2018-2023)
5.1.2 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2024-2029)
5.1.3 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2018-2029)
5.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2018-2029)
5.2.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2018-2023)
5.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2024-2029)
5.2.3 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2018-2029)
5.3 Global Nicotinamide Phosphoribosyltransferase Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Genentech, Inc.
6.1.1 Genentech, Inc. Corporation Information
6.1.2 Genentech, Inc. Description and Business Overview
6.1.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
6.1.5 Genentech, Inc. Recent Developments/Updates
6.2 Angelini Group
6.2.1 Angelini Group Corporation Information
6.2.2 Angelini Group Description and Business Overview
6.2.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio
6.2.5 Angelini Group Recent Developments/Updates
6.3 Calico LLC
6.3.1 Calico LLC Corporation Information
6.3.2 Calico LLC Description and Business Overview
6.3.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio
6.3.5 Calico LLC Recent Developments/Updates
6.4 FORMA Therapeutics, Inc.
6.4.1 FORMA Therapeutics, Inc. Corporation Information
6.4.2 FORMA Therapeutics, Inc. Description and Business Overview
6.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2018-2023)
6.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
6.4.5 FORMA Therapeutics, Inc. Recent Developments/Updates
6.5 OncoTartis, Inc.
6.5.1 OncoTartis, Inc. Corporation Information
6.5.2 OncoTartis, Inc. Description and Business Overview
6.5.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2018-2023)
6.5.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
6.5.5 OncoTartis, Inc. Recent Developments/Updates
6.6 Karyopharm Therapeutics, Inc.
6.6.1 Karyopharm Therapeutics, Inc. Corporation Information
6.6.2 Karyopharm Therapeutics, Inc. Description and Business Overview
6.6.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
6.6.5 Karyopharm Therapeutics, Inc. Recent Developments/Updates
6.7 Aurigene Discovery Technologies Limited
6.6.1 Aurigene Discovery Technologies Limited Corporation Information
6.6.2 Aurigene Discovery Technologies Limited Description and Business Overview
6.6.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio
6.7.5 Aurigene Discovery Technologies Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicotinamide Phosphoribosyltransferase Industry Chain Analysis
7.2 Nicotinamide Phosphoribosyltransferase Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicotinamide Phosphoribosyltransferase Production Mode & Process
7.4 Nicotinamide Phosphoribosyltransferase Sales and Marketing
7.4.1 Nicotinamide Phosphoribosyltransferase Sales Channels
7.4.2 Nicotinamide Phosphoribosyltransferase Distributors
7.5 Nicotinamide Phosphoribosyltransferase Customers
8 Nicotinamide Phosphoribosyltransferase Market Dynamics
8.1 Nicotinamide Phosphoribosyltransferase Industry Trends
8.2 Nicotinamide Phosphoribosyltransferase Market Drivers
8.3 Nicotinamide Phosphoribosyltransferase Market Challenges
8.4 Nicotinamide Phosphoribosyltransferase Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Nicotinamide Phosphoribosyltransferase Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Nicotinamide Phosphoribosyltransferase Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Nicotinamide Phosphoribosyltransferase Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) of Key Manufacturers (2018-2023)
    Table 5. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Nicotinamide Phosphoribosyltransferase Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Nicotinamide Phosphoribosyltransferase Average Price (USD/MT) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Nicotinamide Phosphoribosyltransferase, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Product Type & Application
    Table 12. Global Key Manufacturers of Nicotinamide Phosphoribosyltransferase, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Nicotinamide Phosphoribosyltransferase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Phosphoribosyltransferase as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Nicotinamide Phosphoribosyltransferase Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2018-2023) & (K MT)
    Table 18. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2018-2023)
    Table 19. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2024-2029) & (K MT)
    Table 20. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2024-2029)
    Table 21. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2018-2023)
    Table 23. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2024-2029)
    Table 25. North America Nicotinamide Phosphoribosyltransferase Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2018-2023) & (K MT)
    Table 27. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2024-2029) & (K MT)
    Table 28. North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2018-2023) & (K MT)
    Table 32. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2024-2029) & (K MT)
    Table 33. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Region (2018-2023) & (K MT)
    Table 37. Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Region (2024-2029) & (K MT)
    Table 38. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Nicotinamide Phosphoribosyltransferase Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Nicotinamide Phosphoribosyltransferase Sales by Country (2018-2023) & (K MT)
    Table 42. Latin America Nicotinamide Phosphoribosyltransferase Sales by Country (2024-2029) & (K MT)
    Table 43. Latin America Nicotinamide Phosphoribosyltransferase Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Nicotinamide Phosphoribosyltransferase Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2018-2023) & (K MT)
    Table 47. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2024-2029) & (K MT)
    Table 48. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) by Type (2018-2023)
    Table 51. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) by Type (2024-2029)
    Table 52. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2018-2023)
    Table 53. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2024-2029)
    Table 54. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2018-2023)
    Table 57. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2024-2029)
    Table 58. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Type (2018-2023)
    Table 59. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Type (2024-2029)
    Table 60. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) by Application (2018-2023)
    Table 61. Global Nicotinamide Phosphoribosyltransferase Sales (K MT) by Application (2024-2029)
    Table 62. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2018-2023)
    Table 63. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2024-2029)
    Table 64. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2018-2023)
    Table 67. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2024-2029)
    Table 68. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Application (2018-2023)
    Table 69. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Application (2024-2029)
    Table 70. Genentech, Inc. Corporation Information
    Table 71. Genentech, Inc. Description and Business Overview
    Table 72. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 73. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product
    Table 74. Genentech, Inc. Recent Developments/Updates
    Table 75. Angelini Group Corporation Information
    Table 76. Angelini Group Description and Business Overview
    Table 77. Angelini Group Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 78. Angelini Group Nicotinamide Phosphoribosyltransferase Product
    Table 79. Angelini Group Recent Developments/Updates
    Table 80. Calico LLC Corporation Information
    Table 81. Calico LLC Description and Business Overview
    Table 82. Calico LLC Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 83. Calico LLC Nicotinamide Phosphoribosyltransferase Product
    Table 84. Calico LLC Recent Developments/Updates
    Table 85. FORMA Therapeutics, Inc. Corporation Information
    Table 86. FORMA Therapeutics, Inc. Description and Business Overview
    Table 87. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 88. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product
    Table 89. FORMA Therapeutics, Inc. Recent Developments/Updates
    Table 90. OncoTartis, Inc. Corporation Information
    Table 91. OncoTartis, Inc. Description and Business Overview
    Table 92. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 93. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product
    Table 94. OncoTartis, Inc. Recent Developments/Updates
    Table 95. Karyopharm Therapeutics, Inc. Corporation Information
    Table 96. Karyopharm Therapeutics, Inc. Description and Business Overview
    Table 97. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 98. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product
    Table 99. Karyopharm Therapeutics, Inc. Recent Developments/Updates
    Table 100. Aurigene Discovery Technologies Limited Corporation Information
    Table 101. Aurigene Discovery Technologies Limited Description and Business Overview
    Table 102. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 103. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product
    Table 104. Aurigene Discovery Technologies Limited Recent Developments/Updates
    Table 105. Key Raw Materials Lists
    Table 106. Raw Materials Key Suppliers Lists
    Table 107. Nicotinamide Phosphoribosyltransferase Distributors List
    Table 108. Nicotinamide Phosphoribosyltransferase Customers List
    Table 109. Nicotinamide Phosphoribosyltransferase Market Trends
    Table 110. Nicotinamide Phosphoribosyltransferase Market Drivers
    Table 111. Nicotinamide Phosphoribosyltransferase Market Challenges
    Table 112. Nicotinamide Phosphoribosyltransferase Market Restraints
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Nicotinamide Phosphoribosyltransferase
    Figure 2. Global Nicotinamide Phosphoribosyltransferase Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Nicotinamide Phosphoribosyltransferase Market Share by Type in 2022 & 2029
    Figure 4. Hormone Product Picture
    Figure 5. Lipids Product Picture
    Figure 6. Small Molecule Compounds Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Nicotinamide Phosphoribosyltransferase Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Nicotinamide Phosphoribosyltransferase Market Share by Application in 2022 & 2029
    Figure 10. Parkinson's Disease
    Figure 11. Acute Lung Injury
    Figure 12. Breast Cancer
    Figure 13. Others
    Figure 14. Global Nicotinamide Phosphoribosyltransferase Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Nicotinamide Phosphoribosyltransferase Market Size (2018-2029) & (US$ Million)
    Figure 16. Global Nicotinamide Phosphoribosyltransferase Sales (2018-2029) & (K MT)
    Figure 17. Global Nicotinamide Phosphoribosyltransferase Average Price (USD/MT) & (2018-2029)
    Figure 18. Nicotinamide Phosphoribosyltransferase Report Years Considered
    Figure 19. Nicotinamide Phosphoribosyltransferase Sales Share by Manufacturers in 2022
    Figure 20. Global Nicotinamide Phosphoribosyltransferase Revenue Share by Manufacturers in 2022
    Figure 21. The Global 5 and 10 Largest Nicotinamide Phosphoribosyltransferase Players: Market Share by Revenue in 2022
    Figure 22. Nicotinamide Phosphoribosyltransferase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 23. Global Nicotinamide Phosphoribosyltransferase Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 24. North America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2018-2029)
    Figure 25. North America Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2018-2029)
    Figure 26. U.S. Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Canada Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2018-2029)
    Figure 29. Europe Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2018-2029)
    Figure 30. Germany Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. France Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. U.K. Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Italy Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Russia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Asia Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2018-2029)
    Figure 36. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2018-2029)
    Figure 37. China Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Japan Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. South Korea Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. India Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Australia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Taiwan Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Indonesia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Thailand Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Malaysia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Philippines Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Latin America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2018-2029)
    Figure 48. Latin America Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2018-2029)
    Figure 49. Mexico Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Brazil Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Argentina Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2018-2029)
    Figure 53. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2018-2029)
    Figure 54. Turkey Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. UAE Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Global Sales Market Share of Nicotinamide Phosphoribosyltransferase by Type (2018-2029)
    Figure 58. Global Revenue Market Share of Nicotinamide Phosphoribosyltransferase by Type (2018-2029)
    Figure 59. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Type (2018-2029)
    Figure 60. Global Sales Market Share of Nicotinamide Phosphoribosyltransferase by Application (2018-2029)
    Figure 61. Global Revenue Market Share of Nicotinamide Phosphoribosyltransferase by Application (2018-2029)
    Figure 62. Global Nicotinamide Phosphoribosyltransferase Price (USD/MT) by Application (2018-2029)
    Figure 63. Nicotinamide Phosphoribosyltransferase Value Chain
    Figure 64. Nicotinamide Phosphoribosyltransferase Production Process
    Figure 65. Channels of Distribution (Direct Vs Distribution)
    Figure 66. Distributors Profiles
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Potassium Nitrate (KNO3) Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5U3847
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Complement Deficiency Tests Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22P5979
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Folic Acid Injection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33X610
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Hygienic Butterfly Valves Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16X3680
Mon Apr 15 00:00:00 UTC 2024

Add to Cart